Dr Maggie Lin, MD | |
95 Highland Ave Ste 130, Bethlehem, PA 18017-9483 | |
(610) 868-1100 | |
(610) 868-1111 |
Full Name | Dr Maggie Lin |
---|---|
Gender | Female |
Speciality | Vascular Surgery |
Experience | 12 Years |
Location | 95 Highland Ave Ste 130, Bethlehem, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255695409 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | MT202320 (Pennsylvania) | Secondary |
2086S0129X | Surgery - Vascular Surgery | MD466757 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
St Lukes Quakertown Hospital | Quakertown, PA | Hospital |
St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Luke's Physician Group Inc | 6709798333 | 1739 |
Gslpg, Inc | 7810226875 | 227 |
St Lukes Warren Physician Group Pc | 9739093675 | 314 |
News Archive
When Alzheimer's disease strikes, the entire brain doesn't crumble at once. Instead the mind unravels like grim clockwork, beginning with the telltale degradation of a group of brain cells in the entorhinal cortex.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that positive new preclinical data was presented on RG-012 for the treatment of renal dysfunction in Alport syndrome patients at the American Society of Nephrology's Kidney Week 2014 meeting being held November 11-16, 2014 in Philadelphia, PA.
Sectra has signed a partnership agreement with the Spanish company Fundación García Muñoz S.L. Founded in 1920, Fundación García Muñoz is a leading supplier of medical equipment and has an extensive customer base in both the private and public healthcare sectors in Spain.
A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and A*STAR's Genome Institute of Singapore (GIS) has identified a novel method to treat triple-negative breast cancer (TNBC). They discovered that cancer cells switch between different cell states and are able to change from being less aggressive ('epithelial') to being more aggressive ('mesenchymal'), and vice versa.
› Verified 2 days ago
Entity Name | St Lukes Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
When Alzheimer's disease strikes, the entire brain doesn't crumble at once. Instead the mind unravels like grim clockwork, beginning with the telltale degradation of a group of brain cells in the entorhinal cortex.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that positive new preclinical data was presented on RG-012 for the treatment of renal dysfunction in Alport syndrome patients at the American Society of Nephrology's Kidney Week 2014 meeting being held November 11-16, 2014 in Philadelphia, PA.
Sectra has signed a partnership agreement with the Spanish company Fundación García Muñoz S.L. Founded in 1920, Fundación García Muñoz is a leading supplier of medical equipment and has an extensive customer base in both the private and public healthcare sectors in Spain.
A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and A*STAR's Genome Institute of Singapore (GIS) has identified a novel method to treat triple-negative breast cancer (TNBC). They discovered that cancer cells switch between different cell states and are able to change from being less aggressive ('epithelial') to being more aggressive ('mesenchymal'), and vice versa.
› Verified 2 days ago
Entity Name | Star Community Health Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033686159 PECOS PAC ID: 7618215237 Enrollment ID: O20190206002009 |
News Archive
When Alzheimer's disease strikes, the entire brain doesn't crumble at once. Instead the mind unravels like grim clockwork, beginning with the telltale degradation of a group of brain cells in the entorhinal cortex.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that positive new preclinical data was presented on RG-012 for the treatment of renal dysfunction in Alport syndrome patients at the American Society of Nephrology's Kidney Week 2014 meeting being held November 11-16, 2014 in Philadelphia, PA.
Sectra has signed a partnership agreement with the Spanish company Fundación García Muñoz S.L. Founded in 1920, Fundación García Muñoz is a leading supplier of medical equipment and has an extensive customer base in both the private and public healthcare sectors in Spain.
A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and A*STAR's Genome Institute of Singapore (GIS) has identified a novel method to treat triple-negative breast cancer (TNBC). They discovered that cancer cells switch between different cell states and are able to change from being less aggressive ('epithelial') to being more aggressive ('mesenchymal'), and vice versa.
› Verified 2 days ago
Entity Name | Gslpg, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366006702 PECOS PAC ID: 7810226875 Enrollment ID: O20190917001763 |
News Archive
When Alzheimer's disease strikes, the entire brain doesn't crumble at once. Instead the mind unravels like grim clockwork, beginning with the telltale degradation of a group of brain cells in the entorhinal cortex.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that positive new preclinical data was presented on RG-012 for the treatment of renal dysfunction in Alport syndrome patients at the American Society of Nephrology's Kidney Week 2014 meeting being held November 11-16, 2014 in Philadelphia, PA.
Sectra has signed a partnership agreement with the Spanish company Fundación García Muñoz S.L. Founded in 1920, Fundación García Muñoz is a leading supplier of medical equipment and has an extensive customer base in both the private and public healthcare sectors in Spain.
A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and A*STAR's Genome Institute of Singapore (GIS) has identified a novel method to treat triple-negative breast cancer (TNBC). They discovered that cancer cells switch between different cell states and are able to change from being less aggressive ('epithelial') to being more aggressive ('mesenchymal'), and vice versa.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Maggie Lin, MD 95 Highland Ave Ste 130, Bethlehem, PA 18017-9483 Ph: (610) 868-1100 | Dr Maggie Lin, MD 95 Highland Ave Ste 130, Bethlehem, PA 18017-9483 Ph: (610) 868-1100 |
News Archive
When Alzheimer's disease strikes, the entire brain doesn't crumble at once. Instead the mind unravels like grim clockwork, beginning with the telltale degradation of a group of brain cells in the entorhinal cortex.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that positive new preclinical data was presented on RG-012 for the treatment of renal dysfunction in Alport syndrome patients at the American Society of Nephrology's Kidney Week 2014 meeting being held November 11-16, 2014 in Philadelphia, PA.
Sectra has signed a partnership agreement with the Spanish company Fundación García Muñoz S.L. Founded in 1920, Fundación García Muñoz is a leading supplier of medical equipment and has an extensive customer base in both the private and public healthcare sectors in Spain.
A team of clinicians and scientists from the National Cancer Centre Singapore (NCCS), Singapore General Hospital (SGH) and A*STAR's Genome Institute of Singapore (GIS) has identified a novel method to treat triple-negative breast cancer (TNBC). They discovered that cancer cells switch between different cell states and are able to change from being less aggressive ('epithelial') to being more aggressive ('mesenchymal'), and vice versa.
› Verified 2 days ago
Luis Devia, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 | |
Dr. Rupam K Das, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2597 Schoenersville Rd Ste 100, Bethlehem, PA 18017 Phone: 610-402-8900 Fax: 484-884-5594 | |
Dr. Stephen Dingley, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-2255 | |
Brandon Sloan, MD Surgery Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 866-785-8537 | |
Dr. Kaitlin Nguyen, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 | |
Dr. Wayne Bryan Bauerle, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-4000 Fax: 866-691-7505 | |
Dr. Amanda Leigh Gifford, MD Surgery Medicare: Medicare Enrolled Practice Location: 801 Ostrum St, Bethlehem, PA 18015 Phone: 484-526-2255 |